# US 2008/0188796 A1 · Closed-Loop Method for Controlling Insulin Infusion

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0188796 A1
- Document ID: US20080188796A1
- Status: Published application
- Kind: A1
- Application number: 12/098,108
- Filed: 2008-04-04
- Published: 2008-08-07
- Earliest claimed: 1999-06-03
- Assignees: Medtronic MiniMed, Inc.
- Inventors: Garry M. Steil; Kerstin Rebrin
- Web page: https://patentgrep.com/patent/US20080188796A1

## CPC

- A61B 5/14865: {invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors}
- A61B 5/14532: {for measuring glucose, e.g. by tissue impedance measurement}
- A61B 5/14539: {for measuring pH}
- A61B 5/1495: Calibrating or testing of in-vivo probes
- A61B 5/4839: {combined with drug delivery}
- A61B 5/6849: {in combination with a needle set}
- A61B 5/7242: {using integration}
- A61M 5/14244: {adapted to be carried by the patient, e.g. portable on the body}
- A61M 5/158: Needles {for infusions; Accessories therefor, e.g. for inserting infusion needles, or for holding them on the body}
- A61M 5/1582: {Multi-lumen needles}
- A61M 5/1723: {using feedback of body parameters, e.g. blood sugar or pressure}
- G16H 20/17: delivered via infusion or injection
- A61M 2005/1581: {Right-angle needle-type devices}
- A61M 2005/1726: {the body parameters being measured at, or proximate to, the infusion site}
- A61M 2230/201: Glucose concentration
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

A closed loop infusion system controls the rate that fluid is infused into the body of a user. The closed loop infusion system includes a sensor system, a controller, and a delivery system. The sensor system includes a sensor for monitoring a condition of the user. The sensor produces a sensor signal, which is representative of the condition of the user. The sensor signal is used to generate a controller input. The controller uses the controller input to generate commands to operate the delivery system. The delivery system infuses a liquid into the user at a rate dictated by the commands from the controller. Preferably, the sensor system monitors the glucose concentration in the body of the user, and the liquid infused by the delivery system into the body of the user includes insulin.

## Claims

### Claim at position 1

-32. (canceled)

### Claim 33

A method for calculating the amount of insulin to be infused into a body of a user, the method comprising:
obtaining a blood glucose concentration of the user;
generating a controller input based on the blood glucose concentration; and
generating infusion calculations by a proportional plus, integral plus, derivative (PID) controller from the controller input using at least one preset controller gain;
wherein the at least one preset controller gain is selected such that the infusion commands generated by the PID controller infuses insulin into the body of the user in response to the glucose concentration at a rate similar to a rate that beta cells would release insulin in an individual with a healthy normally functioning pancreas; and
wherein the an automatic blood withdrawal system is used to obtain the blood glucose concentration of the user.

### Claim 34 (depends on 33)

The method according to claim 33, further comprising:
infusing insulin based on the infusion calculations from the PID controller;
wherein the insulin is infused through an IV catheter connected to the body of the user.

### Claim 35 (depends on 33)

The method according to claim 33, wherein the at least one preset controller gain includes at least one tuning parameter that further modifies the commands generated by the PID controller to create an insulin concentration profile that more closely resembles the insulin concentration profile that would be generated by the release of insulin by beta cells in an individual with a healthy normally functioning pancreas.

### Claim 36 (depends on 35)

The method according to claim 35, wherein the at least one tuning parameter is an integrator leak.

### Claim 37 (depends on 35)

The method according to claim 35, wherein the at least one tuning parameter is a lead/lag compensator.

### Claim 38 (depends on 35)

The method according to claim 35, wherein the at least one tuning parameter is an integrator clip.

### Claim 39 (depends on 35)

The method according to claim 35, wherein the at least one tuning parameter is a feedback of predicted plasma insulin.

### Claim 40 (depends on 33)

The method according to claim 33, wherein the at least one preset controller gain is selected by a method that includes the step of measuring an insulin response of at least one individual with a healthy normally functioning pancreas and calculating the at least one controller gain that causes the infusion commands to generally match the insulin response of the at least one individual.

### Claim 41 (depends on 33)

The method according to claim 33, wherein the PID controller is a bilinear PID controller.
